Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients

Anticancer Research

Volumn 32, Issue 5, 2012, Pages 1621-1626

  Levy, Miroslav ^a   Benesova, Lucie ^b   Lipska, Ludmila ^a   Belsanova, Barbora ^b   Minarikova, Petra ^a,c   Veprekova, Gabriela ^a,c   Zavoral, Miroslav ^a,c   Minarik, Marek ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Genomac Research Institute   (Czech Republic)

^c IPVZ   (Czech Republic)

Author keywords

CA19 9; CEA; cfDNA; Colorectal cancer; DCE; DNA mutation; Tumour markers

Indexed keywords

APC PROTEIN; B RAF KINASE; BEVACIZUMAB; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DNA; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; TUMOR CELL FREE DNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BYPASS SURGERY; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURGERY; CELL FREE SYSTEM; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; GASTROENTEROSTOMY; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; RECTOSIGMOIDAL CANCER; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CARCINOMA; RECTUM HEMORRHAGE; SIGMOID CARCINOMA; SMALL INTESTINE RESECTION; SOMATIC MUTATION; SPLEEN CANCER; SYNCHRONOUS SPLENIC FLEXURE ADENOCARCINOMA;

AGED; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84861512882     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gan S, Wilson K and Hollington P: Surveilance of patients following surgery with curative intent for colorectal cancer. World J Gastronterol 13: 3816-3823, 2007. (Pubitemid 47272306)
2. Kaneko I, Tanaka S, Oka S, Yoshida S, Hiyama T, Arihiro K, Shimamoto F and Chayama K: Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer. World J Gastroenterol 13: 3829-3835, 2007. (Pubitemid 47272308)
3. Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M and Fuchs CS: Evaluation of Markers for CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer by a Large Population-Based Sample. J Mol Diagn 9: 305-314, 2007. (Pubitemid 47305066)
4. Famulski W, Sulkowska M, Wincewicz A, Kedra B, Pawlak K, Zalewski B, Sulkowski S, Koda M and Baltaziak M.: P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients. Neoplasma 53: 43-48, 2006. (Pubitemid 43206938)
5. Vlassov VV, Laktionov PP and Rykova EY: Circulating nucleic acids as a potential source for cancer biomarkers. Curr Mol Med 10: 142-165, 2010.
6. Mandel P, Metais P: Les acidos nucleiques du plasma sanguin chez l'homme. C R Seances Soc Biol Fil 142: 241-243, 1948.
7. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD and Knippers R: DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61: 1659-1665, 2001. (Pubitemid 34292602)
8. Bendich A, Wilczok T and Borenfreund E: Circulating DNA as possible factor in oncogenesis. Science 148: 374-376, 1965.
9. Leon SA, Shapiro B, Sklaroff DM and Yaros MJ: Free DNA in the serum of cancer patiens and the effect of therapy. Cancer Res 37: 646-650, 1977. (Pubitemid 8051621)
10. Shapiro B, Chakrabarty M, Cohn EM and Leon SA: Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 51: 2116-2120, 1983. (Pubitemid 13092467)
11. Behera D, Gumbhir K, Malik SK and Dani HM: Lung cancer and circulating DNA. Indian J Chest Dis Allied Sci 28: 54-55, 1986.
12. Anker P, Lefort F, Vasioukhin V, Lyautey J, Lederrey C, Chen XQ, Stroun M, Mulcahy HE and Farthing MJ: K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 112: 1114-1120, 1997. (Pubitemid 27157521)
13. Silva JM, Dominguez G, Garcia JM, Gonzalez R, Villanueva MJ, Navarro F, Provencio M, San Martin S, Espana P and Bonilla F: Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res 59: 3251-3256, 1999. (Pubitemid 29316030)
14. Kamat AA, Baldwin M, Urbauer D, Dang D, Han LY, Godwin A, Karlan BY, Simpson JL, Gershenson DM, Coleman RL, Bischoff FZ and Sood AK: Plasma cell free DNA in ovarian cancer: an independent prognostic biomarker. Cancer 116: 1918-1925, 2010.
15. Jung K, Stephan C, Lewandowski M, Klotzek S, Jung M, Kristiansen G, Lein M, Loening SA and Schnorr D: Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer. Cancer Lett 18: 173-180, 2004. (Pubitemid 38230124)
16. Choi JJ, Reich CF and Pisetsky DS: The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 115: 55-62, 2005.
17. Stroun M, Lyautey J, Lederrey C, Olson-Sand A and Anker P: About the possible origin and mechanism of circulating DNA: apoptosis and active DNA repase. Clin Chim Acta 313: 139-142, 2001. (Pubitemid 33016703)
18. Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C and Beljanski M: Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46: 318-322, 1989. (Pubitemid 19216753)
19. Diehl F, Schmidt K, Durkee KH, Moore KJ, Goodman SN, Shuber AP, Kinzler KW and Vogelstein B: Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients. Gastroenterology 135: 489-498, 2008.
20. Diehl F, Li M, He Y, Kinzler KW, Vogelstein B, Dressman D: BEAMing: single-molecule PCR on microparticles in water-inoil emulsions. Nat Methods 3: 551-559, 2006. (Pubitemid 43941774)
21. Bjørheim J, Minarik M, Gaudernack G and Ekstrøm PO. Evaluation of denaturing conditions in analysis of DNA variants applied to multi-capillary electrophoresis instruments. J Sep Sci 26: 1163-1168, 2003. (Pubitemid 37086802)
22. Ekstrom PO, Khrapko K, Li-Sucholeiki XC, Hunter IW and Thilly WG: Analysis of mutational spectra by denaturing capillary electrophoresis. Nat Protoc 3: 1153-1166, 2008.
23. Minarik M, Minarikova L, Hrabikova M, Minarikova P, Hrabal P and Zavoral M: Application of Cycling Gradient Capillary Electrophoresis (CGCE) to Clinical Screening of APC, K-ras and DCC Point Mutations in Patients with Sporadic Colorectal Tumors. Electrophoresis 25: 1016-1021, 2004. (Pubitemid 38578940)
24. Pesek M, Benesova L, Belsanova B, Mukensnabl P, Bruha F and Minarik M: Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status. Anticancer Res 29: 2767-2773, 2009.
25. Salek C, Minarikova P, Benesova L, Nosek V, Strnad R, Zavoral M and Minarik M: Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer. Anticancer Res 29: 1803-1810, 2009.
26. Thinssen MA, Swinkels DW, Ruers TJ and de Kok JB: Difference between free circulating plasma and serum DNA in patiens with colorectal liver metastases. Anticancer Res 22: 421-425, 2002. (Pubitemid 34475333)